Stay updated on Carisbamate Safety in Lennox-Gastaut Syndrome Clinical Trial
Sign up to get notified when there's something new on the Carisbamate Safety in Lennox-Gastaut Syndrome Clinical Trial page.

Latest updates to the Carisbamate Safety in Lennox-Gastaut Syndrome Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAdded 'Revision: v3.3.3' to the Record History and removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' entries.SummaryDifference0.2%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedThe history list shows a new revision entry (v3.3.2) and removal of the previous revision (v3.3.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page history now shows a new revision entry v3.3.1, replacing the previous v3.2.0 entry.SummaryDifference0.1%

- Check51 days agoChange DetectedRemoved the banner with the government funding/operating status notice from the page; core trial record data and history remain unchanged.SummaryDifference0.7%

- Check66 days agoChange DetectedNew screenshot shows updates to the Record History for NCT04062981, with revised study status entries across multiple versions. These changes reflect the ongoing evolution of the trial record.SummaryDifference0.1%

- Check94 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference12%

Stay in the know with updates to Carisbamate Safety in Lennox-Gastaut Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carisbamate Safety in Lennox-Gastaut Syndrome Clinical Trial page.